Eledon Pharmaceuticals, Inc.ELDNNASDAQ

Revenue (LTM)

Net Income (LTM)

$-46M

-26.1% YoY

Free Cash Flow

$-62M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	-0	-0↓91.3%	-0↓0.3%	-0↑4.0%	0
Operating Income	-37	-40↓7.9%	-43↓8.1%	-71↓64.1%	0
Net Income	-35	-88↓154.9%	-117↓32.5%	-36↑69.0%	-46↓26.1%
EBITDA	-37	-88↓138.9%	-116↓32.6%	-35↑69.5%	0
EPS Diluted	-2.33	-6.13↓163.1%	-1.64↑73.2%	-0.75↑54.3%	-28.73↓3730.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	85	56↓33.5%	5↓91.8%	21↑345.6%	23↑11.0%
Total Current Assets	88	60↓32.6%	56↓5.7%	144↑156.1%	136↓5.6%
Total Assets	171	93↓45.6%	89↓4.0%	177↑99.2%	169↓4.7%
Total Current Liabilities	4	6↑47.1%	4↓39.8%	12↑197.2%	18↑58.5%
Total Liabilities	7	9↑31.4%	82↑850.7%	59↓27.6%	32↓45.6%
Total Equity	164	84↓48.7%	7↓91.4%	118↑1539.0%	81↓31.4%
Total Debt	1	1↓3.0%	0↓48.7%	1↑149.1%	1↓32.8%
Net Debt	-84	-56↑33.8%	-4↑92.4%	-20↓363.3%	-22↓13.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-29	-28↑1.7%	-40↓39.1%	-47↓19.6%	-62↓31.9%
Capital Expenditure	0	0	0	0	0
Free Cash Flow	-29	-28↑1.7%	-40↓39.1%	-47↓19.6%	-62↓31.9%
Stock-Based Comp	8	8↑3.2%	7↓19.7%	13↑100.5%	10↓20.4%
Net Change in Cash	-29	-28↑3.2%	-52↓82.2%	16↑130.8%	2↓85.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance